Mission Pharmacal Overview
- Year Founded
-
1946

- Status
-
Private
- Employees
-
260

- Latest Deal Type
-
Debt - PPP
- Latest Deal Amount
-
$5.52M
Mission Pharmacal General Information
Description
Developer of pharmaceutical products intended to serve physicians, pharmacists, and ultimately, patients. The company mainly focuses on therapeutic areas of women's health, urology, and dermatology. Its core areas of business include branded pharmaceuticals, generic pharmaceuticals, contract development, and manufacturing.
Contact Information
Website
missionpharmacal.comCorporate Office
- P.O. Box 786099
- San Antonio, TX 78278-6099
- United States
Corporate Office
- P.O. Box 786099
- San Antonio, TX 78278-6099
- United States
Mission Pharmacal Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Debt - PPP | 07-Apr-2020 | $5.52M | Completed | Generating Revenue | ||
1. Debt - General | 01-Feb-2020 | Completed | Generating Revenue |
Mission Pharmacal Comparisons
Industry
Financing
Details
Mission Pharmacal Competitors (39)
One of Mission Pharmacal’s 39 competitors is Pfizer Manufacturing Austria, a Corporation company based in Orth An Der Donau, Austria.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Pfizer Manufacturing Austria | Corporation | Orth An Der Donau, Austria | ||||
Abbott India | Corporation | Mumbai, India | ||||
Virtus Pharmaceuticals | Private Equity-Backed | Langhorne, PA | ||||
Glenmark Pharmaceuticals | Corporation | Mumbai, India | ||||
GlaxoSmithKline Consumer Nigeria | Corporation | Lagos, Nigeria |
Mission Pharmacal Patents
Mission Pharmacal Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-11458104-B1 | Enteric coated tiopronin tablet | Active | 21-Jun-2018 | ||
ES-2894679-T3 | Sprayable composition containing zinc oxide and a fluoro-olefin propellant | Active | 14-Feb-2014 | ||
US-20160279061-A1 | Stabilized, sprayable emulsion containing active agent particles | Active | 14-Feb-2014 | ||
CA-2936416-A1 | Stabilized, sprayable emulsion containing active agent particles | Active | 14-Feb-2014 | ||
US-9700510-B2 | Stabilized, sprayable emulsion containing active agent particles | Active | 14-Feb-2014 | A61K9/124 |
Mission Pharmacal Signals
Mission Pharmacal Acquisitions (1)
Mission Pharmacal’s most recent deal was a Merger/Acquisition with Prosolus. The deal was made on 29-May-2015.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Prosolus | 29-May-2015 | Merger/Acquisition | Drug Delivery |
Mission Pharmacal Affiliates
Subsidiaries (1)
Name | Industry | Location | Year Founded |
---|---|---|---|
Biocomp Pharma | San Antonio, TX | 2009 |
Mission Pharmacal FAQs
-
When was Mission Pharmacal founded?
Mission Pharmacal was founded in 1946.
-
Where is Mission Pharmacal headquartered?
Mission Pharmacal is headquartered in San Antonio, TX.
-
What is the size of Mission Pharmacal?
Mission Pharmacal has 260 total employees.
-
What industry is Mission Pharmacal in?
Mission Pharmacal’s primary industry is Pharmaceuticals.
-
Is Mission Pharmacal a private or public company?
Mission Pharmacal is a Private company.
-
What is Mission Pharmacal’s current revenue?
The current revenue for Mission Pharmacal is
. -
How much funding has Mission Pharmacal raised over time?
Mission Pharmacal has raised $57.5M.
-
Who are Mission Pharmacal’s competitors?
Pfizer Manufacturing Austria, Abbott India, Virtus Pharmaceuticals, Glenmark Pharmaceuticals, and GlaxoSmithKline Consumer Nigeria are some of the 39 competitors of Mission Pharmacal.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »